Problems of Epidemiological Studies of Nosocomial Infections in Russia

Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):4-14

​ Fokin A.A., Galkin D.V., Mischenko V.M., Muravyev A.A., Kozlov R.S., MIX-07 Study Group
nosocomial infections infection control epidemiology
Section
Diseases and Pathogens
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):4-14

Abstract

Nowadays nosocomial infections (NI) remain one of the crucial problems in public health service all over the world. Though antiepidemic actions, the prevalence, mortality rates and NI therapy costs continue to increase. According to the data of international studies and national recommendations routine NI monitoring with pathogens and antimicrobials resistance profile observation promotes decrease in NI incidence and microbial resistance rates. The other important problem leading to nosocomial pathogens spread and NI incidence growth is qualitative infection control programs insufficient use. Results of analytical study on NI incidence conducted as part of «Multicenter analytical study on investigating medical professionals’ and patients’ perception about infection control in various wards of multidisciplinary hospitals in Russian Federation (MIX-07)» and included data from 33 centers (hospitals) from 24 Russian cities with approaches to improve NI registration quality and up to date approaches to NI prevention and monitoring are presented in this article.

  • 1. Horan T.C., Gaynes R. Surveillance of nosocomial infections. In: Mayhall C.G., editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1659-1702.
  • 2. Levy S.B., Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10(Suppl 12):S122-9.
  • 3. Wise R., Hart T., Cars O., et al. Antimicrobial resistance is a major threat to public health. Br Med J 1998; 317:609-10.
  • 4. Siegel J.D., Rhinehart E., Jackson M., Chairello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrugresistant organisms in healthcare settings. 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf.
  • 5. Решедько Г.К., Рябкова Е.Л., Фаращук А.Н., Страчунский Л.С., исследовательская группа РОСНЕТ. Неферментирующие грамотрицательные возбудители нозокомиальных инфекций в ОРИТ России: проблемы антибиотикорезистентности. Клиническая Микробиология и Антимикробная Химиотерапия 2006; 8:232-248.
  • 6. Эйдельштейн М.В., Страчунский Л.С., исследовательская группа РОСНЕТ. Динамика распространенности и чувствительности БЛРСпродуцирующих штаммов энтеробактерий к различным антимикробным препаратам в ОРИТ России. Клиническая Микробиология и Антимикробная Химиотерапия 2005; 7:323-36.
  • 7. Дехнич А.В., Эйдельштейн И.А., Нарезкина А.Д., и др. Эпидемиология антибиотикорезистентности нозокомиальных штаммов Staphylococcus aureus в России: результаты многоцентрового исследования. Клиническая Микробиология и Антимикробная Химиотерапияапия, 2002; 4:325-36.
  • 8. Weinstein R.. Nosocomial infection update. Emerg Infect Dis 1998; 4:416-20.
  • 9. Руководство по инфекционному контролю в стационаре: Пер. с англ./Под ред. Р.П. Венцеля, Т. Бревера, Ж-П. Бутцлера - Смоленск: МАКМАХ, 2003.
  • 10. Роспотребнадзор. «Государственный доклад о санитарно-эпидемиологической обстановке в Российской Федерации в 2006 году». Информация доступна по адресу: www.rospotrebnadzor.ru/docs/doclad/
  • 11. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Смоленск: МАКМАХ, 2007.
  • 12. Joint Commission on Accreditation of Hospitals. Accreditation manual for hospitals. Chicago: Joint Commission on Accreditation of Hospitals, 1976.
  • 13. Department of Health and Human Services Centers for Disease Control and Prevention. National Nosocomial Surveillance System (NNIS). Available at: http://www.cdc.gov/ncidod/dhqp/nnis.html
  • 14. Письмо МЗ РФ от 17 апреля 2000 г. № 2510/4196-32 «О профилактике внутрибольничных инфекций».
  • 15. Приказ МЗ РФ от 26.11.1997 г. № 345 (Ред. от 05.05.2000) «О совершенствовании мероприятий по профилактике внутрибольничных инфекций в акушерских стационарах».
  • 16. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC Definitions of Nosocomial Infections. In: Olmsted R.N., ed.: APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis: Mosby; 1996: pp. A-1- 20.
  • 17. Hughes J.M. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy 1988; 34:553-61.
  • 18. Jarvis W.R. Handwashing - The Semmelweis lesson forgotten? Lancet 1994; 344:1311-12.
  • 19. Casewell M., Phillips I. Hands as route for transmission for Klebsiella species. Br Med J 1977; 2:1315-17.
  • 20. Conly J.M., Hill S., Ross J., Lertzman J., Louie T.J. Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control 1989; 17:330-39.
  • 21. Doebbeling B.N., Stanley G.L., Sheetz C.T., et al. Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327:88-93.
  • 22. Pittet D., Mourouga P., Perneger T.V. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999; 130:126-30.
  • 23. Ojajarvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. J Hyg (Lond) 1980; 85:193-203.
  • 24. Zaragoza M., Salles M., Gomez J., et al. Handwashing with soap or alcoholic solutions? A randomized clinical trial of its effectiveness. Am J Infect Control 1999; 27:258-61.
  • 25. Pittet D., Dharan S., Touveneau S., et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159:821-6.
  • 26. Trick W.E., Vernon M.O., Hayes R.A., et al. Impact of ring wearing on hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis 2003; 36:1383-90.
  • 27. Safdar N., Marx J., Meyer N.A., et al. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. Am J Infect Control 2006; 34:476-83.
  • 28. Boyce J.M., Pittet D. Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the ICPAC/SHEA/APIC/ IDSA Hand Hygiene Task Force. MMRW Recomm Rep 2002; 51:1- 44.
  • 29. WHO Guidelines for Hand Hygiene in Health Care (Advanced Draft). Geneva: WHO, 2006. http://www.who.patientsafety/challenge/en
  • 30. Siegel J.D., Rhinehart E., Jackson M., Chairello L. Healthcare Infection Control Practices Advisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007. Available at: http://www.cdc. gov/ncidod/dhqp/pdf/isolation2007.pdf.
  • 31. LeDell K., Muto C.A., Jarvis W.R., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:639-41.
  • 32. Sehulster L., Chinn R.Y., CDC, HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 6:1-42.
  • 33. Puzniak L.A., Gillespie K.N., Leet T., et al. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: Is it worth the price? Infect Control Hosp Epidemiol 2004; 25:418-424.
  • 34. Puzniak L.A., Mayfield J., Leet T., et al. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001; 15:151-7.
  • 35. Tarnow-Mordi W.O., Hau C., Warden A., et al. Hospital mortality in relation to staff workload: A 4-year study in an adult intensive-care unit. Lancet 2000; 356:185-9.
  • 36. Joiner G.A., Salisbury D., Bollin G.E. Utilizing quality assurance as a tool for reducing the risk of nosocomial ventilator-associated pneumonia. Am J Medical Quality 1996; 11:100-3.
  • 37. Kelleghan S.I., Salemi C., Padilla S., et al. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control 1993; 21:322-30.
  • 38. Boyce J.M., White R.L., Spruill E.Y., et al. Cost-effective application of the Centers for Disease Control Guideline for Prevention of Nosocomial Pneumonia. Am J Infect Control 1985; 13:228-32.
  • 39. Gaynes R.P., Solomon S. Improving hospital-acquired infection rates: The CDC experience. J Comm J Qual Improv 1996; 22:457-67.
  • 40. Zack J.E., Garrison T., Trovillion E., et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002; 30:2407-12.
  • 41. Babcock H.M., Zack J.E., Garrison T., et al. An education intervention to reduce ventilator-associated pneumonia in an integrated health system. A comparison of effects. Chest 2004; 125:2224-31.
  • 42. Eggimann P., Harbarth S., Constantin M.N., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-8.
  • 43. Bijma R., Girbes A.R., Kleijer D.J., et al. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol 1999; 20:618-20.
  • 44. Warren D.K., Zack J.E., Cox M.J., et al. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003; 31:1959-63.
  • 45. Coopersmith C.M., Rebmann T.L., Zack J.E., et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002; 30:59-64.
  • 46. Warren D.K., Zack J.E., Mayfield J.L., et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004; 126:1612-8.
  • 47. Thoren J-B, Kaelin R.M., Jolliet P., et al. Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease. Crit Care Med 1995; 23:1807- 15.
  • 48. Berwick D.M. Continuous improvement as an idea in healthcare. N Engl J Med 1989; 320:53-6.
  • 49. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilatorassociated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531- 9.
  • 50. Kirn P.W., Harris A.D., Roghmann M.C., et al. Epidemiological risk factors for isolation of ceftriaxoneresistant versus-susceptible Citrobacter freundii in hospitalized patients. Antimicrob Agents Chemother 2003; 47:2882-7.
  • 51. Nava S., Ambrosino N., Clini E., et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med 1998; 128:721-8.
  • 52. Antonelli M., Conti G., Rocco M., et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339:429-35.
  • 53. Nourdine K., Combes P., Carlton M.J., et al. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999; 25:567-73.
  • 54. Fuqua W.C., Greenberg E.P. Listening in on bacteria: acyl-homoserine lactone signaling. Nat Rev Mol Cell Biol 2002; 3:685-95.
  • 55. Erwin A.L., VanDevanter D.R. The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections? Curr Opin Pulm Med 2002; 8: 547-51.
  • 56. Donlan R.M., Costerton J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
  • 57. Trautner B.W., Darouiche R.O. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 2004; 164:842-50.
  • 58. Saint S., Savel R.H., Matthay M.A. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med 2002; 165:1475-9.
  • 59. Zabramski J.M., Whiting D., Darouiche R.O., et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003; 98:725-30.
  • 60. Darouiche R.O., Raad I.I., Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340:1-8.
  • 61. Maki D.G., Stolz S.M., Wheeler S., et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized control trial. Ann Intern Med 1997; 127:257-66.
  • 62. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261-7.
  • 63. Maki D.G., Knasinski V., Halvorson K., et al. A novel silver hydrogel-impregnated indwelling urinary catheter reduces CAUTIs: a prospective double blind trial [Abstract]. Infect Control Hosp Epidemiol 1998; 19:682.
  • 64. Maki D.G., Knasinski V., Halvorson K., et al. A prospective randomized investigator-blinded trial of a novel nitrofurazone-impregnated urinary catheter. Proceedings and Abstracts of the English International Congress on Infectious Diseases. 15-18 May 1998, Boston, MA. Boston: International Soc for Infectious Diseases; 1998.
  • 65. Bologna R.A., Tu L.M., Polansky M., et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology 1999; 54:982-7.
  • 66. Shinefield H., Black S., Fattom A., et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346:491-6.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared